Tenax Therapeutics, Inc.
TENX
$14.61
$0.775.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.54M | -15.80M | -10.85M | -10.41M | -6.27M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.79M | 5.62M | 4.61M | 4.14M | 969.00K |
| Change in Net Operating Assets | -2.67M | 1.03M | -25.00K | -701.00K | 1.77M |
| Cash from Operations | -13.42M | -9.16M | -6.26M | -6.97M | -3.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 11.61M | 3.06M | 278.00K | 347.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.76M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 23.22M | 1.83M |
| Cash from Financing | 11.61M | 3.06M | 278.00K | 23.56M | 67.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.80M | -6.09M | -5.99M | 16.60M | -3.46M |